Cargando…
IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
Background Treatment for neonatal alloimmune thrombocytopenia (NAIT) primarily involves maternal administration of intravenous immunoglobulin (IVIG) therapy and prednisone according to protocols based on risk stratification. While IVIG is generally well tolerated, hematologic side effects are a pot...
Autores principales: | Herrmann, Alyssa, Samelson-Jones, Benjamin J., Brake, Sami, Samelson, Renee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621970/ https://www.ncbi.nlm.nih.gov/pubmed/28970962 http://dx.doi.org/10.1055/s-0037-1607055 |
Ejemplares similares
-
Three cases of alloimmune mediated pancytopenia in calves resembling bovine neonatal pancytopenia
por: Chantillon, L., et al.
Publicado: (2022) -
A Case of Neonatal Alloimmune Thrombocytopenia Following Maternal Pemphigoid Gestationis
por: Chism, Danielle A, et al.
Publicado: (2023) -
Bovine Neonatal Pancytopenia: Is this alloimmune syndrome caused by vaccine-induced alloreactive antibodies?
por: Bastian, Max, et al.
Publicado: (2011) -
Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events
por: Wienzek-Lischka, Sandra, et al.
Publicado: (2020) -
Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention
por: Brojer, Ewa, et al.
Publicado: (2015)